JAMES CZABAN, a partner and chair of the U.S. Food and Drug Administration practice group at Wiley Rein in Washington, D.C., has joined DLA Piper.
The global legal giant, which saw gross revenue break the $2.5 billion mark for the first time in 2015, added Czaban to its international trade, government affairs, life sciences and regulatory groups in the nation’s capital. Czaban, who enjoys fishing vacations, comes to DLA Piper after seven years at Wiley Rein, whose food, drug and product safety practice he joined back in 2009 after co-chairing the FDA group at Wilmer Cutler Pickering Hale and Dorr.
